Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nathan Frogge

Interventional Cardiology Saint Louis, MO Medical Doctor

NPI 1982017943 CMS profile 874912

1020 N Mason Rd, Div Im Cardiology, Ste 100, Saint Louis, MO 63141

Open in the dashboard

General payments

$44,496

300 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nathan Frogge of Saint Louis, MO is reported in the CMS Open Payments database as having received $44,496 across 300 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,769 93
2024 General $2,153 36
2023 General $1,359 43
2022 General $3,747 50
2021 General $27,461 68
2020 General $752 8
2019 General $255 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nathan Frogge
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Nathan Frogge were reported at $8,769. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Nathan Frogge Interventional Cardiology median Middle half National median
2019 $255 $1,097 $329–$3,048 $163
2020 $752 $473 $161–$1,480 $114
2021 $27,461 $677 $233–$1,827 $132
2022 $3,747 $978 $333–$2,724 $149
2023 $1,359 $1,136 $382–$2,986 $160
2024 $2,153 $1,181 $395–$3,326 $164
2025 $8,769 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $22,885 83 payments
  2. Abbott Laboratories $6,618 26 payments
  3. Edwards Lifesciences Corporation $5,518 49 payments
  4. Abiomed $1,978 24 payments
  5. Boston Scientific Corporation $1,699 19 payments
  6. Philips Electronics North America Corporation $1,589 17 payments
  7. Penumbra, Inc. $734 7 payments
  8. W. L. Gore & Associates, Inc. $727 5 payments
  9. Shockwave Medical, Inc $559 5 payments
  10. Medtronic Vascular, Inc. $280 2 payments
  11. Other $1,907 63 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $21,500 2 payments
  2. Food and Beverage $15,610 253 payments
  3. Travel and Lodging $6,544 39 payments
  4. Consulting Fee $530 1 payment
  5. Education $312 5 payments
Products named General payments · program years 2019–2025
  1. CoreValve Evolut $18,899 20 payments
  2. COREVALVE EVOLUT R $2,976 43 payments
  3. SAPIEN 3 Ultra RESILIA $1,468 17 payments
  4. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $1,288 11 payments
  5. MitraClip System $1,054 11 payments
  6. Impella $957 7 payments
  7. General - Therapies $879 5 payments
  8. Indigo System $734 7 payments
  9. GORE CARDIOFORM Septal Occluder $727 5 payments
  10. ONYX FRONTIER $664 14 payments
  11. Other $8,786 148 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

300 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record